METFORMIN SR 500, 750, 1000 MG TABLETS

METFORMIN SR 500, 750, 1000 MG TABLETS
Product Description

Approved country
500 mg : UK, Czech, Latvia, Hungary, The Netherlands, Poland
750mg : UK, Ireland, The Netherlands, Poland
1000mg : UK, The Netherlands, Poland

Composition 500 mg: One prolonged release tablet contains 500 mg metformin hydrochloride equivalent to 390 mg metformin.
750 mg: One prolonged release tablet contains 750 mg metformin hydrochloride equivalent to 585 mg metformin .
1000 mg: One prolonged release tablet contains 1000 mg metformin hydrochloride equivalent to 780 mg metformin .

Pharmaceutical Form Prolonged-release tablet
500 mg: White, shallow convex, capsule-shaped tablet marked “XR” on one side , and blank on the other side, dimension : 20x9mm.
750 mg: White, shallow convex, capsule-shaped tablet marked “SR 1” on one side, and blank on the other side, dimension : 20x9mm.
1000 mg: White, shallow convex, capsule-shaped tablet marked “SR 2” on one side, and blank on the other side, dimension : 22.25x9mm.

Therapeutic indications Treatment of type 2 diabetes mellitus in adults, particularly in overweight patients, when dietary management and exercise alone does not result in adequate glycaemic control.
METFORMIN SR may be used as monotherapy or in combination with other oral antidiabetic agents, or with insulin

Type of container
500mg: PVC/PVDC aluminium blisters.
Blister packs of 28, 30, 56, 60 & 120 prolonged-release tablets.

750mg: PVC/PVDC aluminium blisters.
Blister packs of 28, 30, 56, 60 & 120 prolonged-release tablets.

1000mg: PVC/PVDC aluminium blisters.
Blister packs of 28, 30, 56, 60 & 120 prolonged-release tablets.

Shelf life
Shelf life as packaged for sale: 36 months

Read more Show less

PT FERRON PAR PHARMACEUTICALS

  • Country/Region:
    Indonesia
  • On CPHI since:
    2019
  • Certificates:
    3
  • Employees:
    500 - 999
Company types
CMO/CDMO
Primary activities
Contract Manufacturer
Pharmaceutical Company (generic finished products)
View company profile
Categories
more categories Show less
Specifications
  • Supplied from
    Indonesia
More specifications Fewer specifications
Sales Markets
Show more Show less

PT FERRON PAR PHARMACEUTICALS

  • Country/Region:
    Indonesia
  • On CPHI since:
    2019
  • Certificates:
    3
  • Employees:
    500 - 999
Company types
CMO/CDMO
Primary activities
Contract Manufacturer
Pharmaceutical Company (generic finished products)
View company profile

More Products from PT FERRON PAR PHARMACEUTICALS (2)

  • FERRON PHARMA (GENERAL NON BETA LAKTAM)

    Product FERRON PHARMA (GENERAL NON BETA LAKTAM)

    Ferron Par Pharmaceuticals is a member of Dexa Medica Group, Top 3 Indonesia’s biggest companies and one of the top generic pharmaceutical company in South East Asia, with multiple manufacturing sites across the country. Ferron itself was established in 2002, with the capability to manufacture Fi...
  • HERBAL PRODUCT OF DEXA

    Product HERBAL PRODUCT OF DEXA

    Herbal product profile : Senokot (local Brand is Herbavomitz) Brand is our product that already marketed to Canada & US market